Differences in coagulation-relevant parameters: Comparing cryoprecipitate and a human fibrinogen concentrate
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0290571 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Sophia Stanford und 7 weiteren Autor:innen. Beteiligte Einrichtung: Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom. Hauptthemen laut MEDLINE: Cell-Derived Microparticles, Hematologic Agents, Hemostatics. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Octapharma AG.
Abstract (Originalsprache)
Background
Variable fibrinogen content within cryoprecipitate makes accurate dosing challenging in patients with coagulopathic bleeding, in addition to pathogen transmission risks associated with its administration. Purified and standardized human fibrinogen concentrates (HFCs) represent reliable alternatives. Full cryoprecipitate characterization is required to inform selection of an appropriate fibrinogen source for supplementation therapy.
Methods
Extended biochemical comparison of pooled cryoprecipitate and HFC ( Fibryga , Octapharma) was performed using commercially available assays to determine levels of variability in cryoprecipitate and HFC. In addition to standard procoagulant factors, measurements included activities of platelet-derived microparticles (PMPs) and plasminogen, and levels of fibrin degradation products.
Results
Cryoprecipitate contains lower fibrinogen levels than HFC (4.83 vs .19.73 g/L; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom.
- Octapharma AG, Lachen, Switzerland.
- Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna, Austria.
- Faculty of Medicine, Centre for Cancer Immunology, University of Southampton, University Hospital Southampton, Southampton, United Kingdom.
ORCID-Profile: Sophia Stanford, Ashok Roy
Förderung
- Octapharma AG
Zitieren
APA
Stanford, S., Roy, A., Cecil, T., Hegener, O., Schulz, P., Turaj, A., Lim, S., & Arbuthnot, E. (2023). Differences in coagulation-relevant parameters: Comparing cryoprecipitate and a human fibrinogen concentrate. PLOS ONE. https://doi.org/10.1371/journal.pone.0290571
Vancouver
Stanford S, Roy A, Cecil T, Hegener O, Schulz P, Turaj A, et al. Differences in coagulation-relevant parameters: Comparing cryoprecipitate and a human fibrinogen concentrate. PLOS ONE. 2023. doi:10.1371/journal.pone.0290571
BibTeX
@article{Stanford2023,
author = {Stanford, Sophia and Roy, Ashok and Cecil, Tom and Hegener, Oliver and Schulz, Petra and Turaj, Anna and Lim, Sean and Arbuthnot, Emily},
title = {Differences in coagulation-relevant parameters: Comparing cryoprecipitate and a human fibrinogen concentrate},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0290571}
}
EUVIMED